Publicaciones en colaboración con investigadores/as de Universidad de Cádiz (19)

2024

  1. Clustering COVID-19 ARDS patients through the first days of ICU admission. An analysis of the CIBERESUCICOVID Cohort

    Critical Care, Vol. 28, Núm. 1

  2. Long noncoding RNA profiling in respiratory specimens from COVID-19 patients

    Management, Body Systems, and Case Studies in COVID-19 (Elsevier), pp. 285-294

2023

  1. A blood microRNA classifier for the prediction of ICU mortality in COVID-19 patients: a multicenter validation study

    Respiratory Research, Vol. 24, Núm. 1

  2. Effect of viral storm in patients admitted to intensive care units with severe COVID-19 in Spain: a multicentre, prospective, cohort study

    The Lancet Microbe, Vol. 4, Núm. 6, pp. e431-e441

  3. Effects of intubation timing in patients with COVID-19 throughout the four waves of the pandemic: a matched analysis

    The European respiratory journal, Vol. 61, Núm. 3

  4. Key Factors Associated With Pulmonary Sequelae in the Follow-Up of Critically Ill COVID-19 Patients

    Archivos de Bronconeumologia, Vol. 59, Núm. 4, pp. 205-215

  5. Procalcitonin and C-reactive protein to rule out early bacterial coinfection in COVID-19 critically ill patients

    Intensive Care Medicine, Vol. 49, Núm. 8, pp. 934-945

2022

  1. Major candidate variables to guide personalised treatment with steroids in critically ill patients with COVID-19: CIBERESUCICOVID study

    Intensive Care Medicine, Vol. 48, Núm. 7, pp. 850-864

  2. Prognostic implications of comorbidity patterns in critically ill COVID-19 patients: A multicenter, observational study

    The Lancet Regional Health - Europe, Vol. 18

2021

  1. Correction to: The evolution of the ventilatory ratio is a prognostic factor in mechanically ventilated COVID-19 ARDS patients (Critical Care, (2021), 25, 1, (331), 10.1186/s13054-021-03727-x)

    Critical Care

  2. The evolution of the ventilatory ratio is a prognostic factor in mechanically ventilated COVID-19 ARDS patients

    Critical Care, Vol. 25, Núm. 1

2020

  1. Emerging role of microRNAs in dilated cardiomyopathy: evidence regarding etiology

    Translational Research, Vol. 215, pp. 86-101

  2. Peripheral microRNA panels to guide the diagnosis of familial cardiomyopathy

    Translational Research, Vol. 218, pp. 1-15

2018

  1. Dilated Cardiomyopathy Due to BLC2-Associated Athanogene 3 (BAG3) Mutations

    Journal of the American College of Cardiology, Vol. 72, Núm. 20, pp. 2471-2481

  2. Non-coding RNAs and exercise: Pathophysiological role and clinical application in the cardiovascular system

    Clinical Science, Vol. 132, Núm. 9, pp. 925-942

  3. Plasma microRNAs as biomarkers for Lamin A/C-related dilated cardiomyopathy

    Journal of Molecular Medicine, Vol. 96, Núm. 8, pp. 845-856

2017

  1. Familial dilated cardiomyopathy: A multidisciplinary entity, from basic screening to novel circulating biomarkers

    International Journal of Cardiology, Vol. 228, pp. 870-880

2016

  1. Circulating long-non coding RNAs as biomarkers of left ventricular diastolic function and remodelling in patients with well-controlled type 2 diabetes

    Scientific Reports, Vol. 6

  2. Genetic basis of dilated cardiomyopathy

    International Journal of Cardiology, Vol. 224, pp. 461-472